This is a pretty awesome man to have on your side! He may have even invested in Biocurex. Someone is fronting the money...

Dr. Phil Gold, C.C., O.Q., M.D., Ph.D. attended McGill University where he obtained four degrees. His Ph.D. thesis title was "Carcinoembryonic Antigens (CEA) of the Human Digestive System" which, along with the description of alpha-fetoprotein (AFP), ushered in the modern era of human tumor marker research along with the diagnostic impact that this work has had over the past 35 years.

The assay for CEA developed by Gold, together with PSA, have become the most used markers for human cancer diagnosis and monitoring worldwide. In recognition of his scientific contributions, Dr. Gold has been the recipient of many international awards and honors. He holds positions as physician-in-chief, Department of Medicine, The Montreal General Hospital; Douglas G. Cameron, professor of medicine, McGill University; professor, Departments of Physiology and Oncology, McGill University and the director of the McGill University Medical Clinic at The Montreal General Hospital. This year is the 40th anniversary for his discovery of CEA and the title of his ISOBM 2005 lecture is: “CEA - 40 years after” which will include a discussion on the future of cancer markers and RECAF.